Liquidia (LQDA) Shares Outstanding (2019 - 2026)
Liquidia (LQDA) posted quarterly Shares Outstanding (Entity) of $88.3 million for Q1 2026, up 3.53% year-over-year from $85.3 million in Q1 2025, and up 1.27% quarter-over-quarter from $87.2 million in Q4 2025.
Liquidia (LQDA) Shares Outstanding (2019 - 2026) Analysis & Trends
Liquidia's Shares Outstanding (Entity) history runs 8 years deep, the most recent figure standing at $88.3 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 3.53% year-over-year to $88.3 million; the TTM figure through Mar 2026 stood at $88.3 million (up 3.53% YoY), while the FY2025 annual figure was $87.2 million, up 2.98% from the prior year.
- Shares Outstanding (Entity) for Q1 2026 stood at $88.3 million, up from $87.2 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $88.3 million in Q1 2026, with the low at $53.1 million in Q1 2022.
- The 5-year median for Shares Outstanding (Entity) is $76.3 million (2024), against an average of $74.4 million.
- The sharpest annual moves came in 2023 and 2024: Shares Outstanding (Entity) advanced 0.61% in 2023, then jumped 30.27% in 2024.
- Liquidia's Shares Outstanding (Entity) stood at $64.5 million in 2022, then grew by 6.37% to $68.6 million in 2023, then rose by 23.39% to $84.7 million in 2024, then gained by 2.98% to $87.2 million in 2025, then advanced by 1.27% to $88.3 million in 2026.
- Business Quant data shows LQDA's Shares Outstanding (Entity) at $88.3 million in Q1 2026, $87.2 million in Q4 2025, and $86.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 417.60 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 42.60 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 101.00 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 499.50 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | 832.44 Mn |
| 10 | Liquidia | 6.52 Bn | 6.23 Bn | 160.92 Mn | 88.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 88.01 Mn |
| Mar 31, 2026 | 88.01 Mn |
| Dec 31, 2025 | 86.06 Mn |
| Sep 30, 2025 | 86.33 Mn |
| Jun 30, 2025 | 85.59 Mn |
| Mar 31, 2025 | 85.17 Mn |
| Dec 31, 2024 | 78.71 Mn |
| Sep 30, 2024 | 78.32 Mn |
| Jun 30, 2024 | 76.44 Mn |
| Mar 31, 2024 | 75.39 Mn |
| Dec 31, 2023 | 64.99 Mn |
| Sep 30, 2023 | 64.86 Mn |
| Jun 30, 2023 | 64.79 Mn |
| Mar 31, 2023 | 64.66 Mn |
| Dec 31, 2022 | 60.96 Mn |
| Sep 30, 2022 | 64.46 Mn |
| Jun 30, 2022 | 62.18 Mn |
| Mar 31, 2022 | 52.47 Mn |
| Dec 31, 2021 | 49.68 Mn |
| Sep 30, 2021 | 52.08 Mn |